
Rofitec AQ 75mg Injection
Marketer
Speciality Meditech Pvt Ltd
Salt Composition
Diclofenac (75mg)
Overview Rofitec AQ 75mg Injection
Aquaflex 75mg Injection provides analgesia, effectively managing pain, inflammation, rigidity, and articular discomfort associated with conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma. Administered intravenously by a medical practitioner only – self-injection is strictly prohibited. Prior to treatment, disclose any history of cardiovascular events (e.g., stroke, heart disease). Report any injection site reactions (pain, swelling, erythema) to your physician immediately. Common adverse effects encompass nausea, emesis, cephalalgia, and injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with hematological parameters. Chronic use carries a risk of severe complications, including gastrointestinal hemorrhage and nephropathy.
Uses of Rofitec AQ 75mg Injection
Analgesia
Major Benefits of Rofitec AQ 75mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Rofitec AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Rofitec AQ 75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Rofitec AQ 75mg Injection works:
Rofitec AQ 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated signs of inflammation, such as redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Rofitec AQ 75mg Injection and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Administering Rofitec AQ 75mg Injection during pregnancy carries established risks to fetal development and is therefore contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Rofitec AQ 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Rofitec AQ 75mg Injection may induce adverse reactions potentially impairing driving capabilities.
KidneyCAUTION
For individuals with kidney impairment, administration of Rofitec AQ 75mg Injection requires careful monitoring. A modified dosage of Rofitec AQ 75mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Administering Rofitec AQ 75mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification of Rofitec AQ 75mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Rofitec AQ 75mg Injection :
Omit a scheduled Rofitec AQ 75mg Injection? Seek your physician's guidance.
Facts to Know About Rofitec AQ 75mg Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
